CAPhO's Breaking the Habit: Early Discontinuation of Antibiotics in Febrile Neutropenia webinar, presented by Kyia Hynes took place on Friday, June 26, 2026 at 10:00 PT.
The webinar discussed febrile neutropenia management, and reviewed evidence supporting early discontinuation of antibiotics in patients with no identified source of infection. It also highlighted principals of antimicrobial resistance. As well as demonstrating an antimicrobial stewardship initiative that was implemented at the Arthur J.E. Child Comprehensive Cancer Centre, by applying this evidence.
Febrile neutropenia is a medical emergency that cancer patients face. However, antibiotic resistance is a global threat. Managing antibiotics for these vulnerable patients is a delicate balancing act. We want to maximize clinical benefit while minimizing unintended consequences. Historically it was thought that antibiotics should be continued until neutrophil recovery to reduce mortality. New evidence suggests otherwise.
Watch Early Discontinuation of Antibiotics in Febrile Neutropenia Webinar
Learning Objectives
- Define febrile neutropenia and understand empiric management.
- Understand principals of antibiotic resistance.
- Analyze evidence supporting the safety of early discontinuation of antibiotics in febrile neutropenia patients, without a source of infection.
- Apply antimicrobial stewardship initiative to febrile neutropenia patient.